BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11798580)

  • 41. Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
    Thörn I; Forestier E; Botling J; Thuresson B; Wasslavik C; Björklund E; Li A; Lindström-Eriksson E; Malec M; Grönlund E; Torikka K; Heldrup J; Abrahamsson J; Behrendtz M; Söderhäll S; Jacobsson S; Olofsson T; Porwit A; Lönnerholm G; Rosenquist R; Sundström C
    Br J Haematol; 2011 Mar; 152(6):743-53. PubMed ID: 21250970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse.
    Kim YJ; Kim DW; Lee S; Min CK; Goh HG; Kim SH; Lee JY; Kim YL; Kim HJ; Kim HJ; Lee JW; Kim TG; Min WS; Kim CC
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):718-25. PubMed ID: 15389438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.
    Gardiner N; Lawler M; O'Riordan J; De'Arce M; McCann SR
    Leukemia; 1997 Apr; 11 Suppl 3():512-5. PubMed ID: 9209441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The monitoring of BCR-ABL mRNA by reverse transcription PCR in patients undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukemia with a positive Philadelphia chromosome].
    Román J; Castillejo JA; Jiménez A; Maldonado J; Torres A
    Med Clin (Barc); 1999 Dec; 113(20):779-82. PubMed ID: 10680143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
    zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
    Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acceleration of chronic myeloid leukemia correlates with calcitonin gene hypermethylation.
    Malinen T; Palotie A; Pakkala S; Peltonen L; Ruutu T; Jansson SE
    Blood; 1991 Jun; 77(11):2435-40. PubMed ID: 2039824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylation pattern of calcitonin (CALCA) gene in pediatric acute leukemia.
    Ismail EA; El-Mogy MI; Mohamed DS; El-Farrash RA
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):534-42. PubMed ID: 21423046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypermethylation of 5'-region of the human calcitonin gene in leukemias: structural features and diagnostic significance.
    Marinitch DV; Vorobyev IA; Holmes JA; Zakharchenko NS; Dyachenko OV; Buryanov YI; Shevchuk TV
    Biochemistry (Mosc); 2004 Mar; 69(3):340-9. PubMed ID: 15061703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of the polymerase chain reaction to detect hypermethylation in the calcitonin gene. A new, sensitive approach to monitor tumor cells in acute myelogenous leukemia.
    Fukuhara T; Hooper WC; Baylin SB; Benson J; Pruckler J; Olson AC; Evatt BL; Vogler WR
    Leuk Res; 1992 Oct; 16(10):1031-40. PubMed ID: 1405705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypermethylation of the calcitonin gene in acute lymphoblastic leukaemia is associated with unfavourable clinical outcome.
    Roman J; Castillejo JA; Jimenez A; Bornstein R; Gonzalez MG; del Carmen Rodriguez M; Barrios M; Maldonado J; Torres A
    Br J Haematol; 2001 May; 113(2):329-38. PubMed ID: 11380396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NCCN task force report: molecular markers in leukemias and lymphomas.
    Radich JP; Zelenetz AD; Chan WC; Croce CM; Czuczman MS; Erba HP; Horning SJ; Houldsworth J; Smith BD; Snyder DS; Sundar HM; Wetzler M; Winter JN
    J Natl Compr Canc Netw; 2009 Jul; 7 Suppl 4():S1-34, quiz S35-6. PubMed ID: 19635230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Residual methylation of tumor suppressor gene promoters, RASSF6 and RASSF10, as novel biomarkers for minimal residual disease detection in adult acute lymphoblastic leukemia.
    Younesian S; Shahkarami S; Ghaffari P; Alizadeh S; Mehrasa R; Ghaffari SH
    Ann Hematol; 2019 Dec; 98(12):2719-2727. PubMed ID: 31486880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of minimal residual disease in leukemia.
    Faderl S; Kantarjian HM; Talpaz M; Estrov Z
    Int J Oncol; 2000 Dec; 17(6):1277-87. PubMed ID: 11078816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia.
    Ardjmand A; de Bock CE; Shahrokhi S; Lincz LF; Boyd AW; Burns GF; Thorne RF
    Hematology; 2013 Nov; 18(6):315-22. PubMed ID: 23433465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical significance of CASP8AP2 gene methylation in childhood acute lymphoblastic leukemia].
    Liu FF; Liu X; Wang KL; Li WJ; Deng GR; Gao C; Zhao XX; Wu MY; Cui L; Li ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):6-11. PubMed ID: 25687037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypermethylation of the 5' region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies.
    Baylin SB; Fearon ER; Vogelstein B; de Bustros A; Sharkis SJ; Burke PJ; Staal SP; Nelkin BD
    Blood; 1987 Aug; 70(2):412-7. PubMed ID: 3607279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA methylation patterns in the calcitonin gene region at first diagnosis and at relapse of acute lymphoblastic leukemia (ALL).
    Leegwater PA; Lambooy LH; De Abreu RA; Bökkerink JP; van den Heuvel LP
    Leukemia; 1997 Jul; 11(7):971-8. PubMed ID: 9204977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What does MRD in leukemia really mean?
    Goldman JM; Gale RP
    Leukemia; 2014 May; 28(5):1131. PubMed ID: 24170026
    [No Abstract]   [Full Text] [Related]  

  • 60. Abnormal regional hypermethylation of the calcitonin gene in myelodysplastic syndromes.
    Dhodapkar M; Grill J; Lust JA
    Leuk Res; 1995 Oct; 19(10):719-26. PubMed ID: 7500648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.